IP Library Granted Patent US 12,357,207
Granted Patent B2
US 12,357,207 · App. 18/447,222 · Granted Jul 15, 2025

Sensor for a continuous biological monitor having nitric oxide releasing compound

Inventors: Qinyi Yan (San Diego, CA); Robert James Boock (Carlsbad, CA); Jessie Haskamp (San Diego, CA); Huashi Zhang (San Juan Capistrano, CA)
Assignee: Allez Health Inc.
A61B5/14865A61B5/14532A61B5/265A61B5/266A61B5/268A61B2562/125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,357,207
App. No.
18/447,222
Granted
Jul 15, 2025
Kind
B2
Abstract

A subcutaneous sensor for use with a continuous glucose monitor includes a working electrode and a reference electrode. The reference electrode comprises a reference substrate, an ion limiting layer over the reference substrate and a composition for releasing nitric oxide (NO). The composition has a NO release compound, a hydrophilic material and a hydrophobic material. A subcutaneous sensor for use with a continuous glucose monitor includes a reference electrode comprising a composition for releasing nitric oxide (NO). The composition has a NO release compound, a hydrophilic material and a hydrophobic material. The reference electrode is positioned separate from a working electrode.

Claims (33)

1. A subcutaneous sensor comprising:

a working electrode of the subcutaneous sensor for use with a continuous glucose monitor; and

a reference electrode of the subcutaneous sensor comprising:

a reference substrate;

an ion limiting layer over the reference substrate; and

a composition for releasing nitric oxide (NO), the composition having a NO release compound, a hydrophilic material and a hydrophobic material.

2. The subcutaneous sensor of claim 1 , wherein the working electrode comprises:

a conductive substrate;

an interference layer over the conductive substrate;

an enzyme layer over the interference layer, the enzyme layer comprising an enzyme for reacting with in-vivo glucose in body fluid of a patient; and

a glucose limiting layer over the enzyme layer that limits an amount of the in-vivo glucose from the body fluid of the patient that passes to the enzyme layer.

3. The subcutaneous sensor of claim 1 , wherein the ion limiting layer of the reference electrode is selected from polyurethane, cellulosic, polyvinyl chloride (PVC) or combinations thereof.

4. The subcutaneous sensor of claim 1 , wherein the NO release compound of the composition is selected from S-nitrosothiol, NONOate, L-arginine, nitrovasodilator or combinations thereof.

5. The subcutaneous sensor of claim 1 , wherein the hydrophilic material of the composition is selected from polyvinylpyrrolidone (PVP), polyvinyl alcohol, polyacrylic acid, polyethylene oxide (PEO), silane-PEO (Si-PEO), PEO compounds, polyethylene glycol (PEG), or combinations thereof.

6. The subcutaneous sensor of claim 1 , wherein the hydrophobic material of the composition is selected from polyurethane, cellulosic, polyvinyl chloride (PVC), silicone or combinations thereof.

7. The subcutaneous sensor of claim 1 , wherein the composition is part of the ion limiting layer of the reference electrode.

8. The subcutaneous sensor of claim 1 , wherein the composition is a reference outer layer over the ion limiting layer of the reference electrode.

9. The subcutaneous sensor of claim 1 , wherein the composition is part of the ion limiting layer and a reference outer layer over the ion limiting layer.

10. The subcutaneous sensor of claim 1 , further comprising a paste over the reference substrate, wherein the composition is part of the paste, between the paste and the ion limiting layer, or part of the paste and between the paste and the ion limiting layer.

11. The subcutaneous sensor of claim 1 , wherein the working electrode includes the composition for releasing the NO, the NO release compound of the composition being S-nitroso-N-acetylpenicillamine (SNAP), the hydrophilic material of the composition being polyvinylpyrrolidone (PVP), and the hydrophobic material of the composition being polyurethane.

12. A subcutaneous sensor comprising:

a reference electrode of the subcutaneous sensor for use with a continuous glucose monitor comprising a composition for releasing nitric oxide (NO), the composition having a NO release compound, a hydrophilic material and a hydrophobic material;

wherein the reference electrode is positioned separate from a working electrode of the subcutaneous sensor.

13. The subcutaneous sensor of claim 12 , wherein the reference electrode further comprises:

a reference substrate; and

an ion limiting layer over the reference substrate.

14. The subcutaneous sensor of claim 12 , wherein the NO release compound of the composition is selected from S-nitrosothiol, NONOate, L-arginine, nitrovasodilator or combinations thereof.

15. The subcutaneous sensor of claim 12 , wherein the hydrophilic material of the composition is selected from polyvinylpyrrolidone (PVP), polyvinyl alcohol, polyacrylic acid, polyethylene oxide (PEO), silane-PEO (Si-PEO), PEO compounds, polyethylene glycol (PEG), or combinations thereof.

16. The subcutaneous sensor of claim 12 , wherein the hydrophobic material of the composition is selected from polyurethane, cellulosic, polyvinyl chloride (PVC), silicone or combinations thereof.

17. The subcutaneous sensor of claim 13 , wherein the composition is part of the ion limiting layer of the reference electrode.

18. The subcutaneous sensor of claim 13 , wherein the composition is a reference outer layer over the ion limiting layer of the reference electrode.

19. The subcutaneous sensor of claim 13 , wherein the composition is part of the ion limiting layer and a reference outer layer over the ion limiting layer.

20. The subcutaneous sensor of claim 13 , further comprising a paste over the reference substrate, wherein the composition is part of the paste, between the paste and the ion limiting layer, or part of the paste and between the paste and the ion limiting layer.

Assignments (3)
CHANGE OF NAME Recorded May 17, 2024
From: ZENSE-LIFE INC.
To: ALLEZ HEALTH INC.
Reel/Frame 067456/0852 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2023
From: YAN, QINYI; BOOCK, ROBERT JAMES; HASKAMP, JESSIE; ZHANG, HUASHI
To: ZENSE-LIFE INC.
Reel/Frame 064581/0879 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2023
From: YAN, QINYI; BOOCK, ROBERT JAMES; HASKAMP, JESSIE; ZHANG, HUASHI
To: ZENSE-LIFE INC.
Reel/Frame 064552/0328 →
Continuity (2)
Continuation 17457004 · Nov 30, 2021
Related Publication 20230380735A1 · Nov 30, 2023
References Cited (23)
US 20080262330A1 · Reynolds · 2008 [cited by examiner]
US 20120034169A1 · Schoenfisch · 2012 [cited by examiner]
US 20130245412A1 · Rong et al. · 2013 [cited by applicant]
US 20130261537A1 · Hofler et al. · 2013 [cited by applicant]
US 20130274574A1 · Say et al. · 2013 [cited by applicant]
US 20170135618A1 · Brister et al. · 2017 [cited by applicant]
US 20170238852A1 · Schoenfisch · 2017 [cited by examiner]
US 20180271413A1 · Chaum et al. · 2018 [cited by applicant]
US 20180292346A1 · Collison · 2018 [cited by examiner]
US 20190069820A1 · Chen · 2019 [cited by examiner]
US 20190310218A1 · Boock et al. · 2019 [cited by applicant]
US 20190331656A1 · Chaum et al. · 2019 [cited by applicant]
US 20210322555A1 · Doxey · 2021 [cited by applicant]
US 20220152219A1 · Schoenfisch · 2022 [cited by examiner]
US 20220296867A1 · Avula · 2022 [cited by examiner]
US 20240269353A1 · Tapsak · 2024 [cited by examiner]
KR 101512566B1 · 2015 [cited by applicant]
International Search Report and Written Opinion dated Feb. 7, 2023 for PCT Patent Application No. PCT/IB2022/060404. [cited by applicant]
Koh, A., Lu, Y., & Schoenfisch, M. H. (2013). Fabrication of nitric oxide-releasing porous polyurethane membranes- coated needle-type implantable glucose biosensors. Analytical chemistry, 85(21), 10488-10494. (Year: 201… [cited by applicant]
Notice of Allowance and Fees dated May 15, 2023 for U.S. Appl. No. 17/457,004. [cited by applicant]
Schofield, Jonathon Blake. Design and In Vitro Studies of Nitric Oxide Releasing Glucose Sensor Membranes. 2016. https://doi .org/ 10.17615/wq9a-sq32 (Year: 2016). [cited by applicant]
Soto, R. J., Merricks, E. P., Bellinger, D. A., Nichols, T. C., & Schoenfisch, M. H. (2018). Influence of diabetes on the foreign body response to nitric oxide-releasing implants. Biomaterials, 157, 76-85. (Year: 2018). [cited by applicant]
Yan et al., Intravascular glucose/lactate sensors prepared with nitric oxide releasing poly(lactide-co-glycolide)-based coatings for enhanced biocompatibility, Biosensors and Bioelectronics 26, Apr. 2011, pp. 4276-4282. [cited by applicant]